Literature DB >> 15994572

Modafinil modulates anterior cingulate function in chronic schizophrenia.

Sean A Spence1, Russell D Green, Iain D Wilkinson, Mike D Hunter.   

Abstract

BACKGROUND: Schizophrenia is associated with widespread cognitive deficits that have an impact on social function. Modafinil promotes wakefulness and is reported to enhance cognition. AIMS: To study the acute effects of modafinil administration upon brain activity and cognitive performance in people with chronic schizophrenia.
METHOD: In a randomised double-blind placebo-controlled crossover design, 19 patients received either modafinil (100 mg) or placebo prior to undertaking a working memory task with functional magnetic resonance imaging.
RESULTS: Seventeen patients completed the study and another underwent acute relapse 4 days post-drug. Modafinil administration was associated with significantly greater activation in the anterior cingulate cortex during the working memory task. The anterior cingulate cortex signal correlated with cognitive performance, although only a subset of patients exhibited 'enhancement'.
CONCLUSIONS: Modafinil modulates anterior cingulate cortex function in chronic schizophrenia but its beneficial cognitive effects may be restricted to a subset of patients requiring further characterisation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15994572     DOI: 10.1192/bjp.187.1.55

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  29 in total

Review 1.  The treatment of cognitive impairment in schizophrenia.

Authors:  Donald C Goff; Michele Hill; Deanna Barch
Journal:  Pharmacol Biochem Behav       Date:  2010-11-27       Impact factor: 3.533

Review 2.  Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap.

Authors:  Judith Pratt; Catherine Winchester; Neil Dawson; Brian Morris
Journal:  Nat Rev Drug Discov       Date:  2012-06-22       Impact factor: 84.694

3.  Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals.

Authors:  Dara G Ghahremani; Golnaz Tabibnia; John Monterosso; Gerhard Hellemann; Russell A Poldrack; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

4.  Exacerbation of obsessions with modafinil in 2 patients with medication-responsive obsessive-compulsive disorder.

Authors:  Oguz Tan; Adnan Coban; Nevzat Tarhan; Semra Baripoglu; Funda Guducu; Hasan Basri Izgi; Gokben Hizli; Oznur Ates; Huseyin Bulu
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

5.  A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia.

Authors:  Mohammad Arbabi; Mohaddeseh Bagheri; Farzin Rezaei; Seyyed-Ali Ahmadi-Abhari; Mina Tabrizi; Farahnaz Khalighi-Sigaroudi; Shahin Akhondzadeh
Journal:  Psychopharmacology (Berl)       Date:  2011-09-24       Impact factor: 4.530

6.  Modafinil reverses phencyclidine-induced deficits in cognitive flexibility, cerebral metabolism, and functional brain connectivity.

Authors:  Neil Dawson; Rhiannon J Thompson; Allan McVie; David M Thomson; Brian J Morris; Judith A Pratt
Journal:  Schizophr Bull       Date:  2010-09-01       Impact factor: 9.306

7.  Modulation of fronto-cortical activity by modafinil: a functional imaging and fos study in the rat.

Authors:  Alessandro Gozzi; Valeria Colavito; Paul F Seke Etet; Dino Montanari; Silvia Fiorini; Stefano Tambalo; Angelo Bifone; Gigliola Grassi Zucconi; Marina Bentivoglio
Journal:  Neuropsychopharmacology       Date:  2011-11-02       Impact factor: 7.853

8.  Effect of tolcapone on brain activity during a variable attentional control task: a double-blind, placebo-controlled, counter-balanced trial in healthy volunteers.

Authors:  Sophia C Magalona; Roberta Rasetti; Jingshan Chen; Qiang Chen; Ian Gold; Heather Decot; Joseph H Callicott; Karen F Berman; José A Apud; Daniel R Weinberger; Venkata S Mattay
Journal:  CNS Drugs       Date:  2013-08       Impact factor: 5.749

Review 9.  The orexins/hypocretins and schizophrenia.

Authors:  Ariel Y Deutch; Michael Bubser
Journal:  Schizophr Bull       Date:  2007-08-28       Impact factor: 9.306

10.  A review of modafinil film-coated tablets for attention-deficit/hyperactivity disorder in children and adolescents.

Authors:  Thomas Rugino
Journal:  Neuropsychiatr Dis Treat       Date:  2007-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.